Pancreatic cancer cryoablation treatment applies freezing energy to destroy malignant tissue in the pancreas. This technique offers a palliative and local control option for patients with unresectable or advanced-stage disease.
The procedure is performed under imaging guidance, often in combination with systemic chemotherapy. Cryoablation reduces tumor burden, alleviates pain, and improves quality of life in selected pancreatic cancer patients.
Compared to conventional surgery, cryoablation is less invasive and suitable for patients who cannot tolerate extensive procedures. Its repeatable nature allows for tailored treatment in cases of recurrent or residual tumors.
Indications include locally advanced pancreatic tumors, palliation of obstructive symptoms, and adjunctive therapy to systemic treatments. Careful planning ensures maximal therapeutic benefit with minimized risks.
What Is Pancreatic Cancer Cryoablation Treatment?
Pancreatic cancer cryoablation treatment is especially used in advanced‑stage tumors. This procedure is noted for its high success rate because it destroys cancerous tissue by freezing it. Treatment is performed under local anesthesia with ultrasound and CT guidance. Due to its effectiveness and pain reduction, patients prefer this method. Some key points about cryoablation treatment include:
- A large portion of the pancreatic tumor is successfully destroyed.
- Pain‑causing nerves around the tumor are destroyed during treatment, significantly reducing patient pain.
How Is Pancreatic Cancer Cryoablation Treatment Performed?
Pancreatic cancer cryoablation treatment uses high technology to effectively destroy diseased tissue. The treatment process begins with local anesthesia to ensure patient comfort. Advanced imaging techniques—ultrasound and CT—locate the tumor precisely. Under imaging guidance, thin needles called probes are carefully placed into the tumor mass.
- The number of probes is adjusted according to tumor size:
- Usually 2–3 needles suffice for small tumors,
- while larger tumors may require more needles.
During the procedure, a special gas that can reach extremely low temperatures is passed through the probe tips. This creates a frozen cell mass around the tumor. The freeze‑thaw cycle is repeated several times to effectively destroy tumor tissue. At the end, the probes are removed, completing the treatment.
Are There Side Effects?
After pancreatic cancer cryoablation treatment, some side effects may occur. The extreme cold can lead to various complications. The most common side effects include:
- Pain in the abdominal area,
- Risk of infection,
- Possibility of internal bleeding.
These side effects are generally mild and manageable. However, serious complications can occur rarely. In the post‑treatment period, the patient should be regularly evaluated under doctor supervision.
What Is the Post‑Treatment Process?
The recovery process after pancreatic cancer cryoablation varies depending on the type of procedure. Most patients recover quickly after percutaneous cryosurgery. They are usually expected to return to normal activities within one to three days. Some important points about the recovery process:
First 72 hours:
- Avoid strenuous activities such as heavy lifting.
- Rest is recommended.
First week:
- Normal activities can be gradually increased.
- Full recovery may take seven to ten days.
These timeframes may be shorter or longer depending on the patient’s condition. Healthcare professionals provide individualized advice on when to return to work and resume daily activities.
What Are the Advantages of Pancreatic Cancer Cryoablation Treatment?
Cryoablation offers various advantages in pancreatic cancer treatment, making it an important option for patients. First, its minimally invasive nature reduces patient trauma, contributing to less pain post‑procedure. Additionally, this method provides targeted freezing of tumor cells:
- Precise targeting directly freezes and inactivates the tumor.
- Preservation of healthy tissue ensures minimal damage to surrounding areas.
In terms of safety, cryoablation carries fewer risks compared to other treatments. Patients generally tolerate it well, making it a preferred choice when surgery poses high risk. Moreover, cryoablation can be combined with other therapies, expanding treatment options:
- Extension of the treated area,
- Reduction of bleeding risk,
- Offering a non‑surgical alternative when surgery is not feasible.
Prof. Dr. Özgür Kılıçkesmez is one of Türkiye’s leading interventional radiology and neuroradiology specialists, focusing on minimally invasive endovascular treatments. His primary areas of expertise include aneurysm and stroke treatments, embolization procedures, non-surgical treatments of thyroid and parathyroid diseases, interventional oncology, and peripheral vascular interventions. He currently serves as the Head of the Interventional Radiology and Neuroradiology Department at Istanbul Memorial Göztepe Hospital.
Graduating from Istanbul University Cerrahpaşa Faculty of Medicine in 1997, Prof. Dr. Kılıçkesmez received advanced training in interventional radiology and oncology as a Clinical Fellow at London Guy’s & St Thomas’ and King’s College Hospital between 2012 and 2013. He earned the title of Professor in 2020 and, in the same year, became the Founding Interventional Radiologist at SBÜ Çam and Sakura City Hospital. He also holds the EBIR (European Board of Interventional Radiology) certification.
Prof. Dr. Kılıçkesmez has 94 international and 40 national publications and over 2500 citations. He serves as a reviewer for prestigious journals such as the American Journal of Roentgenology (AJR) and Diagnostic & Interventional Radiology. With his clinical and academic expertise, he is a nationally and internationally recognized authority in stroke treatment, brain aneurysm, embolization, tumor ablation, and minimally invasive treatments of thyroid/parathyroid diseases.
Vaka Örnekleri